Risankizumab Long-term Remission Study

NCT04630652 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Risankizumab-Rzaa
PROCEDURE: Punch biopsies of the skin at baseline visit
PROCEDURE: Punch biopsies of the skin at week 28 visit

Sponsor

Jaehwan Kim

Collaborators

[object Object]
[object Object]